TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer von Yardley, Denise A., Arrowsmith, Edward R., Daniel, Brooke R., Eakle, Janice, Brufsky, Adam, Drosick, David R., Kudrik, Fred, Bosserman, Linda D., Keaton, Mark R., Goble, Sharon A., Bubis, Jeffrey A., Priego, Victor M., Pendergrass, Kelly, Manalo, Yvonne, Bury, Martin, Gravenor, Donald S., Rodriguez, Gladys I., Inhorn, Roger C., Young, Robyn R., Harwin, William N., Silver, Caryn, Hainsworth, John D., Burris, Howard A.

Volltext

Phase I Clinical Trials of Tezacitabine [(E)-2′-Deoxy-2′-(fluoromethylene)cytidine] in Patients with Refractory Solid Tumors von RODRIGUEZ, Gladys I, JONES, Richard E, ORENBERG, Elaine K, STOLTZ, Maxine L, BROOKS, Donald J

Volltext

Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage von Yang, Wenya, Williams, James H, Hogan, Paul F, Bruinooge, Suanna S, Rodriguez, Gladys I, Kosty, Michael P, Bajorin, Dean F, Hanley, Amy, Muchow, Ashley, McMillan, Naya, Goldstein, Michael

Volltext

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial von Iwata, Hiroji, Chia, Stephen K L, Bashford, Anna, Inoue, Kenichi, Armstrong, Anne C, Wong, Alvin, Buyse, Marc, Harvey, Vernon, Smith, John W., Konstantinovic, Zora Neskovic, Rodriguez, Gladys I., Jáñez Martinez, Noelia, Knoop, Ann Soegaard, De Boer, Richard Hendry, Rai, Yoshiaki, Yamamoto, Naohito, Brincat, Stephen, Papish, Steven William, Manalo, Yvonne, Sorensen, Peter Grundtvig, Aogi, Kenjiro, Shimizu, Satoru, Mainwaring, Paul, Chang, Jose, del Barco Berron, Sonia, Dickerson, Laura C., Klein, Leonard M., Ruxer, Robert, Veyret, Corinne, Wagnerova, Maria, Richards, Donald A., Vasileios, Asskikis, Dourthe, Louis Marie, Lu, Yen-Shen, Greenspan, Andrew R., Gonzalez Santiago, Santiago, Perren, Timothy John, Yau, Chung Cheung Thomas, Pikó, Béla, Sato, Nobuaki, Askoy, Sercan, Altundag, Mustafa Kadri, Saip, Pinar, Bajaj, Rajesh, Vestlev, Peter Michael, Dank, Magdolna, Cinieri, Saverio, Suszko-Kazarnowicz, Malgorzata, Yap, Yoon Sim, Chen, Shin-Cheh, Haley, Barbara Bacsik, Inhorn, Roger C., Koynova, Tatyana, Schneeweiss, Andreas, Cubedo Cervera, Ricardo, Urruticoechea Ribate, Ander, Schwartz, Garry H., Mocharnuk, Robert Scott, Alkhouri, Nabiel, Erickson, Nicholette, Traynor, Ann, Volterra, Fabio, Capo, Gerardo, Flaherty, Lawrence E., Baidas, Said, Lybaert, Willem, Holland, David R., Gonzalez Jimenez, Sonia, Vanlemmens, Laurence, Ruggeri, Enzo Maria, Desai, Ajit, Nixon, David Allen, O'Brien, Edward, Lanier, Keith S., Brescia, Frankie Ann, Richard, Vincent, Geldhof, Kurt, Bednarik, Otakar, Schwedler, Kathrin, Fries, Stefan, Klare, Peter, Griesinger, Frank, Trufflandier, Nathalie, Chetiyawardana, Anula D., Papandreou, Christos, Hornyak, Lajos, Simo, Erzsebet, Im, Seock-Ah, Ruit, Jan B., Ciltas, Aydin, Benekli, Mustafa, Conkright, William A., Ottaviano, Yvonne, Delmas, Andrew, Steele, Heather A., Bova, Abby R., Shirinian, Mihran, O'Rourke, Timothy J., Francisco, Michael, Carrillo Flores, Maria Regina

Volltext

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-posit... von Hurvitz, Sara A, Bosserman, Linda D, Chan, David, Hagenstad, Christopher T, Kass, Frederick C, Smith, Frederick P, Rodriguez, Gladys I, Childs, Barrett H, Slamon, Dennis J

Volltext

Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/Carboplatin/Etoposide and Gemcitabine/Irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial von Greco, F. Anthony, Rodriguez, Gladys I., Shaffer, Don W., Hermann, Robert, Litchy, Sharlene, Yardley, Denise A., Burris, Howard A., Morrissey, Lisa H., Erland, Joan B., Hainsworth, John D.

Volltext

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors von DRENGLER, R. L, KUHN, J. G, ELFRING, G. L, LOCKER, P. K, MILLER, L. L, VON HOFF, D. D, ROTHENBERG, M. L, SCHAAF, L. J, RODRIGUEZ, G. I, VILLALONA-CALERO, M. A, HAMMOND, L. A, STEPHENSON, J. A, HODGES, S, KRAYNAK, M. A, STATON, B. A

Volltext

Phase II trial of docetaxel for cholangiocarcinoma von PAZDUR, R, ROYCE, M. E, RODRIGUEZ, G. I, RINALDI, D. A, PATT, Y. Z, HOFF, P. M, BURRIS, H. A

Volltext

Phase I study with the DNA sequence-specific agent adozelesin von Burris, Howard A, Dieras, Veronique C, Tunca, Mehmet, Earhart, Robert H, Eckardt, John R, Rodriguez, Gladys I, Shaffer, Donald S, Fields, Suzanne M, Campbell, Elizabeth, Schaaf, Larry, Kasunic6, Dorothy, Von Hoff, Daniel D

Volltext

A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors von DIAB, S. G, BAKER, S. D, KRAYNAK, M, HAMMOND, L, FINIZIO, M, VON HOFF, D. D, ROWINSKY, E. K, JOSHI, A, BURRIS, H. A, COBB, P. W, VILLALONA-CALERO, M. A, ECKHARDT, S. G, WEISS, G. R, RODRIGUEZ, G. I, DRENGLER, R

Volltext

A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea von RODRIGUEZ, G. I, KUHN, J. G, WEISS, G. R, HILSENBECK, S. G, ECKARDT, J. R, THURMAN, A, RINALDI, D. A, HODGES, S, VON HOFF, D. D, ROWINSKY, E. K

Volltext

A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion von RODRIGUEZ, G. I, KUHN, J. G, VON HOFF, D. D, WEISS, G, DE LA CRUZ, P, NEW, P, FIELDS, S. M, ECKARDT, J. R, CAMPBELL, L, CLARK, G. M, HILSENBECK, S. G

Volltext

Phase I and pharmacokinetic trial of weekly CPT-11 von ROTHENBERG, M. L, KUHN, J. G, ROCK, M. K, VAN HOFF, D. D, BURRIS, H. A, NELSON, J, ECKARDT, J. R, TRISTAN-MORALES, M, HILSENBECK, S. G, WEISS, G. R, SMITH, L. S, RODRIGUEZ, G. I

Volltext

A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer von Weiss, Geoffrey R, Shaffer, Don W, DeMoor, Carl, Rinaldi, David A, Rodriguez, Gladys I, Eckardt, John R, Stephens, Clyde, Von Hoff, Daniel D

Volltext

A Bioavailability and Pharmacokinetic Study of Oral and Intravenous Hydroxyurea von Rodriguez, Gladys I., Kuhn, John G., Weiss, Geoffrey R., Hilsenbeck, Susan G., Eckardt, John R., Thurman, Allison, Rinaldi, David A., Hodges, Stephanie, Von Hoff, Daniel D., Rowinsky, Eric K.

Volltext

First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin's Lymphoma: Phase II Trial von Hainsworth, John D., Litchy, Sharlene, Lamb, M. Ray, Rodriguez, Gladys I., Scroggin, Jr. Carroll, Greco, F. Anthony

Volltext

Evaluation of 96‐hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. A southwest... von Hussain, Maha, Benedetti, Jacqueline, Smith, Roy E., Rodriguez, Gladys I., Schuller, David, Ensley, John

Volltext

Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck : A phase II Southwest Oncology Group study von SMITH, R. E, LEW, D, RODRIGUEZ, G. I, TAYLOR, S. A, SCHULLER, D, ENSLEY, J. F

Volltext

A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors von PEACOCK, N. W, BURRIS, H. A, VON HOFF, D. D, DIERAS, V, SMITH, L, RODRIGUEZ, G. I, ECKARDT, J. R, JONES, S. F, HARDY, J, HOHNEKER, J, BIGLEY, J

Volltext

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma von WOOLLEY, P. V, SCHULTZ, C. J, RODRIGUEZ, G. I, GAMS, R. A, ROWE, K. W, DADEY, M. L, VON HOFF, D. D, MCPHILLIPS, J. J

Volltext